Health Condition 1: N390- Urinary tract infection, site notspecified
Conditions
Interventions
Intervention1: phenazopyridine tablets: 100mg three times a day for three days
Control Intervention1: placebo: three times a day for three days
Sponsors
ANJU JOSHUA
Eligibility
Inclusion criteria
Inclusion criteria: 1. patients with clinical symptoms or laboratory-documented urinary tract infection 2. patient willing to give informed consent
Exclusion criteria
Exclusion criteria: 1. patients who have taken antibiotics in the last month 2. patients with congenital urinary tract abnormalities 3. patients with severe liver/renal impairment ( GFR 4. lactating women, pregnant women in third trimester 5. patients taking any medicine with clinically significant CYP induction or inhibition of nitrofurantoin or phenazopyridine 6. patients with a history of allergies to nitrofurantoin, phenazopyridine , paracetamol
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. clinical symptom improvement with a combination of nitrofurantoin with phenazopyridine 2. adverse drug reactions assessed using WHO-UMC casualty assessment scaleTimepoint: two years | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse drug reaction assessed by WHO-UMC causality assessment scaleTimepoint: two years | — |
Countries
India
Contacts
Public ContactDR SYED SHARIQ NAEEM
Jawaharlal Nehru medical college hospital, Aligarh Muslim University, Aligarh
Outcome results
None listed